Standard on 4,4'-Methylenedianiline for General Industry (29 CFR 1910.1050)

Forms and Documents

Document Name	Status
SS_1218-0184 _ 4,4'-Methylenedianiline for General Industry_07-03-2023_ROCIS.docx Supporting Statement A	2023-07-03
eCFR 1910.1050 (MDA) '23.docx Supplementary Document	2023-06-26
OSH Act Section 8-USC-657(1-21).pdf Supplementary Document	2023-06-06
OSH Sec.655 ('19).pdf Supplementary Document	2023-06-06
OSHA Sec.651('19).pdf Supplementary Document	2023-06-06

IC Document Collections

IC ID	Document Title	Status
260942	Medical Surveillance - Examinations	New
14132	4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)	Modified

ICR Details

OMB Control No: 1218-0184	ICR Reference No: 202306-1218-003
Status: Received in OIRA	Previous ICR Reference No: 201912-1218-011
Agency/Subagency: DOL/OSHA	Agency Tracking No: 1218-0184 (2023)
Title: Standard on 4,4'-Methylenedianiline for General Industry (29 CFR 1910.1050)
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 07/19/2023

	Requested	Previously Approved
Expiration Date	36 Months From Approved	07/31/2023
Responses	584	584
Time Burden (Hours)	317	317
Cost Burden (Dollars)	25,740	24,180

---

Abstract: The purpose of this Standard and its information collection requirements is to provide protection for workers from adverse health effects associated with occupational exposure to Methylenedianiline in General Industry. Employers must monitor worker exposures within the permissible exposure limits, provide workers with medical examinations and training, and establish and maintain worker exposure-monitoring and medical records.

---

Authorizing Statute(s): US Code: 29 USC 655 Name of Law: The Occupational Safety and Health Act
   US Code: 29 USC 651 Name of Law: The Occupational Safety and Health Act
   US Code: 29 USC 657 Name of Law: The Occupational Safety and Health Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 20190	04/05/2023
30-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 46186	07/19/2023
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
4,4'-Methylenedianiline (MDA) for General Industry (29 CFR 1910.1050)
Medical Surveillance - Examinations

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	584	584	0	0	0	0
Annual Time Burden (Hours)	317	317	0	0	0	0
Annual Cost Burden (Dollars)	25,740	24,180	0	0	1,560	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The agency is requesting to maintain the 317 burden hours previously approved for this information collections request. However, OSHA is requesting an increase of $1,560 cost going from $24,180 to $25,740 in capital costs. This increase is due to the cost per medical examinations going from $207 to $219 per exam.

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/19/2023

---